{"id":1396,"createDateTime":"2026-10-07T04:35:32.756Z","archiveDateTime":"2027-12-31T00:00:00.000Z","name":"Acne in Gender-Affirming Care","image":"5cfdbc6378b39637620ca942ec44b9501852d3e94d156d2b1a2fb47f","imageThumbnail":"f7bf04fa60267c97cf09221a427e1d9577f2c49f4f19b6ea16dffc2e","about":"As gender-affirming hormone therapy becomes more common in primary care, GPs are encountering testosterone-related acne. This short-form activity would provide a practical approach to recognising, assessing and managing acne in transgender and gender-diverse patients, including treatment selection, counselling, referral pathways, and balancing effective acne management with continuation of gender-affirming hormone therapy.\n\nThis activity comprises a short educational video, followed by a reflective activity. ***Participants must complete both components*** to qualify for 30 minutes of Reviewing Performance (RP) Hours.\n\n# Learning Outcomes\n1. Outline a best practice approach to recognising and managing testosterone-related acne in patients receiving gender-affirming hormone therapy.\n2. Reflect on how escalation and referral strategies for testosterone-related acne could be integrated into your current practice to optimise patient outcomes.\n3. Apply a practical, guideline-aligned approach to managing testosterone-related acne while supporting continuation of gender-affirming hormone therapy.\n\n# Provider\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com. ","type":"video","summaryViewCount":68,"startDateTime":null,"durationSecs":398,"endDateTime":null,"organisation":{"id":101,"name":"Arrotex","logoImage":"343d2282723763f021df947917df828894bcf90cd0942a7b794bdcd8","logoImageThumbnail":"4cb9c205c6d9ce99135b8445d977a6b5da5a4f07cbd1b9811fbd93f2","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":0,"associations":["RACGP"],"rewards":["Reviewing Performance • 0.5 hours"],"rewardImages":[{"image":"7212bc42e6a3b936c544f2eeffd9806cd98e4d97d30566782015df58","aspectRatio":2.396}],"presenters":[{"id":56042,"specialty":{"id":53,"name":"Dermatology"},"name":"Alex Coe","title":"Dermatologist","profileImage":"64e59d9e56a37101e56abbf99030a5430695899dacc5277668da2a39","profileImageThumbnail":"a8fb7447663345f7ed9be386847a13ab27e0d85a3dc7954dd52d7b4f"}],"relatedEducation":[{"id":1447,"name":"Low ferritin, normal haemoglobin ","image":"f892f5d709d4c9795da1d4c0d98a5fef5844d98d80c3817ed61f2a0f","imageThumbnail":"7197b75ed4e9220df548f073c675338b74d608ede3f5e9601a27d03c","type":"video","startDateTime":null,"durationSecs":375,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1446,"name":"Balancing repletion, tolerability and patient fit ","image":"069c365b1d1c703cb0067d18ad632660f3c10a98b7e4877dc022418d","imageThumbnail":"c6f7e04d9fad4e4fc5f49167a567b311a71ea527eb084db09d66beb1","type":"video","startDateTime":null,"durationSecs":326,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1445,"name":"Adherence, monitoring and treatment failure","image":"42c6101fc6b109852056a409e1fed6c3f0822709743a40eb83dfd3c2","imageThumbnail":"9a2595f379105483f145c46085707f6720a1d5d0551ede0bb34f94f9","type":"video","startDateTime":null,"durationSecs":352,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1441,"name":"What does the McKay study show about oral iron formulation?","image":"81ca5de7c17d1dd41185a9696714ed678ed88cbfd01d72244c358c5f","imageThumbnail":"798f8bbaef4634a9c69c2a37693664f2eecf4d103c7c76e5d5069569","type":"video","startDateTime":null,"durationSecs":247,"associationEducationTypes":[],"organisation":{"id":101,"name":"Arrotex"}},{"id":1405,"name":"Hormonal Acne Management for General Practice","image":"c6507a6d4a2eaa2b0fbec06d1572d229893ec9fbf6aabb7afa540d8f","imageThumbnail":"bb0b3a191abc66b9631de005b87931e2765d514fc7d71ae5d2fd8f57","type":"video","startDateTime":null,"durationSecs":5735,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1388,"name":"The GP's role in second line therapy for Endometriosis","image":"d14cda1b05a5e3f26aba936158372444bfb03ee082bc1034f58a2d3c","imageThumbnail":"b80c45f17a4a4bf9271030173e8e84d94d8cd800849649bc987c1444","type":"video","startDateTime":null,"durationSecs":727,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}}]}